Home LiteratureArticle Details
PMID: 29792988 Published · ppublish English Journal Article

Towards quantitative prediction of the performance of dry powder inhalers by multi-scale simulations and experiments.

International journal of pharmaceutics ·Vol. 547 ·No. 1-2 ·2018-08-25 ·页码 31-43

Nguyen D, Remmelgas J, Björn IN, van Wachem B, Thalberg K

Abstract

This work demonstrates the use of multi-scale simulations coupled with experiments to build a quantitative prediction tool for the performance of adhesive mixtures in a dry powder inhaler (DPI). Using discrete element model (DEM), the behaviour of fine-carrier particle assemblies upon different mechanisms encountered during dose entrainment and dispersion can be described at the individual particle level. Combining these results with computational fluid dynamics (CFD) simulations, the complete dosing event from a DPI can be captured and key performance measures can be extracted. A concept of apparent surface energy, ASE, was introduced to overcome challenges associated with the complex particle properties, e.g. irregular particle shapes and surface roughness. This approach correctly predicts trends observed experimentally regarding API adhesivity, flow rate and device geometry. By incorporating the effects of drug load, critical adhesion and surface energy distributions to the simulation tool, the fine particle fraction could be predicted with good agreement to experiments for two different formulations in two different devices at two flow rates. It is concluded that multi-scale simulations provide a useful tool to support device and formulation development, as well as to gain further insight into the physical mechanisms governing dispersion from DPIs.

Keywords
Apparent surface energy CFD-DEM Dose entrainment Dry powder inhaler Fine particle fraction Multi-scale simulation
MeSH 主题词
Aerosols Budesonide/chemistry Computer Simulation Dry Powder Inhalers Hydrodynamics Lactose/chemistry Models, Theoretical Particle Size Stearic Acids/chemistry
化学物质
Aerosols Stearic Acids stearic acid Budesonide Lactose
作者与单位
共 5 位作者,点击展开单位 / ORCID
Nguyen Duy
Pharmaceutical Technology & Development, AstraZeneca Gothenburg, Mölndal, Sweden.
Remmelgas Johan
Pharmaceutical Technology & Development, AstraZeneca Gothenburg, Mölndal, Sweden.
Björn Ingela Niklasson
Pharmaceutical Technology & Development, AstraZeneca Gothenburg, Mölndal, Sweden.
van Wachem Berend
Mechanical Process Engineering, University of Magdeburg, Germany.
Thalberg Kyrre
Pharmaceutical Technology & Development, AstraZeneca Gothenburg, Mölndal, Sweden. Electronic address: [email protected].
Article Info
Journal
International journal of pharmaceutics
Abbr.
Int J Pharm
ISSN
1873-3476
Corresponding email
Published
2018-08-25
电子出版
2018-00-21
页码
31-43
Language
English
Country/Region
Netherlands
NLM ID
7804127
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]